Fluorine-containing intermediates are chemical raw materials or chemical products used in the process of drug synthesis. Such chemical products can be produced in ordinary chemical plants without a drug production license. Can be used for the synthesis of drugs.

The global Fluorinated Pharmaceutical Intermediates market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Fluorinated Pharmaceutical Intermediates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fluorinated Pharmaceutical Intermediates.

Report Scope

The Fluorinated Pharmaceutical Intermediates market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fluorinated Pharmaceutical Intermediates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Fluorinated Pharmaceutical Intermediates companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Fluorinated Pharmaceutical Intermediates Market Report

Report Metric	Details
Report Name	Fluorinated Pharmaceutical Intermediates Market
CAGR	5%
Segment by Type	Aromatic Fluoride Aliphatic Fluoride
Segment by Application	Antiviral Drug Anti-infectives Drug Antirheumatic Drug Antibacterial Drug Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Lonza, Catalent, Patheon, BASF, Jubilant, Granules, Ganesh, Chemcon, Chemours, Zhejiang Yongtai Technology, Shenzhen Capchem Technology, Zhejiang Zhongxin Fluoride Materials, Jiangsu Feiyu Technology, Shanghai Sinofluoro, Shanghai Aqbiopharma, Hangzhou Fluoro Pharmaceutical, Zhejiang Dayang Biotech, Shandong Feiyuan Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fluorinated Pharmaceutical Intermediates companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Fluorinated Pharmaceutical Intermediates Market report?

Ans: The main players in the Fluorinated Pharmaceutical Intermediates Market are Lonza, Catalent, Patheon, BASF, Jubilant, Granules, Ganesh, Chemcon, Chemours, Zhejiang Yongtai Technology, Shenzhen Capchem Technology, Zhejiang Zhongxin Fluoride Materials, Jiangsu Feiyu Technology, Shanghai Sinofluoro, Shanghai Aqbiopharma, Hangzhou Fluoro Pharmaceutical, Zhejiang Dayang Biotech, Shandong Feiyuan Group

What are the Application segmentation covered in the Fluorinated Pharmaceutical Intermediates Market report?

Ans: The Applications covered in the Fluorinated Pharmaceutical Intermediates Market report are Antiviral Drug, Anti-infectives Drug, Antirheumatic Drug, Antibacterial Drug, Others

What are the Type segmentation covered in the Fluorinated Pharmaceutical Intermediates Market report?

Ans: The Types covered in the Fluorinated Pharmaceutical Intermediates Market report are Aromatic Fluoride, Aliphatic Fluoride

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Aromatic Fluoride

1.2.3 Aliphatic Fluoride

1.3 Market by Application

1.3.1 Global Fluorinated Pharmaceutical Intermediates Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Antiviral Drug

1.3.3 Anti-infectives Drug

1.3.4 Antirheumatic Drug

1.3.5 Antibacterial Drug

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Fluorinated Pharmaceutical Intermediates Market Perspective (2019-2030)

2.2 Fluorinated Pharmaceutical Intermediates Growth Trends by Region

2.2.1 Global Fluorinated Pharmaceutical Intermediates Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Fluorinated Pharmaceutical Intermediates Historic Market Size by Region (2019-2024)

2.2.3 Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Region (2025-2030)

2.3 Fluorinated Pharmaceutical Intermediates Market Dynamics

2.3.1 Fluorinated Pharmaceutical Intermediates Industry Trends

2.3.2 Fluorinated Pharmaceutical Intermediates Market Drivers

2.3.3 Fluorinated Pharmaceutical Intermediates Market Challenges

2.3.4 Fluorinated Pharmaceutical Intermediates Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Fluorinated Pharmaceutical Intermediates Players by Revenue

3.1.1 Global Top Fluorinated Pharmaceutical Intermediates Players by Revenue (2019-2024)

3.1.2 Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Players (2019-2024)

3.2 Global Fluorinated Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Fluorinated Pharmaceutical Intermediates Revenue

3.4 Global Fluorinated Pharmaceutical Intermediates Market Concentration Ratio

3.4.1 Global Fluorinated Pharmaceutical Intermediates Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Fluorinated Pharmaceutical Intermediates Revenue in 2023

3.5 Fluorinated Pharmaceutical Intermediates Key Players Head office and Area Served

3.6 Key Players Fluorinated Pharmaceutical Intermediates Product Solution and Service

3.7 Date of Enter into Fluorinated Pharmaceutical Intermediates Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Fluorinated Pharmaceutical Intermediates Breakdown Data by Type

4.1 Global Fluorinated Pharmaceutical Intermediates Historic Market Size by Type (2019-2024)

4.2 Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Type (2025-2030)

5 Fluorinated Pharmaceutical Intermediates Breakdown Data by Application

5.1 Global Fluorinated Pharmaceutical Intermediates Historic Market Size by Application (2019-2024)

5.2 Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Fluorinated Pharmaceutical Intermediates Market Size (2019-2030)

6.2 North America Fluorinated Pharmaceutical Intermediates Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2019-2024)

6.4 North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Fluorinated Pharmaceutical Intermediates Market Size (2019-2030)

7.2 Europe Fluorinated Pharmaceutical Intermediates Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2019-2024)

7.4 Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size (2019-2030)

8.2 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2019-2024)

8.4 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Fluorinated Pharmaceutical Intermediates Market Size (2019-2030)

9.2 Latin America Fluorinated Pharmaceutical Intermediates Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2019-2024)

9.4 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size (2019-2030)

10.2 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2019-2024)

10.4 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Lonza

11.1.1 Lonza Company Detail

11.1.2 Lonza Business Overview

11.1.3 Lonza Fluorinated Pharmaceutical Intermediates Introduction

11.1.4 Lonza Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.1.5 Lonza Recent Development

11.2 Catalent

11.2.1 Catalent Company Detail

11.2.2 Catalent Business Overview

11.2.3 Catalent Fluorinated Pharmaceutical Intermediates Introduction

11.2.4 Catalent Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.2.5 Catalent Recent Development

11.3 Patheon

11.3.1 Patheon Company Detail

11.3.2 Patheon Business Overview

11.3.3 Patheon Fluorinated Pharmaceutical Intermediates Introduction

11.3.4 Patheon Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.3.5 Patheon Recent Development

11.4 BASF

11.4.1 BASF Company Detail

11.4.2 BASF Business Overview

11.4.3 BASF Fluorinated Pharmaceutical Intermediates Introduction

11.4.4 BASF Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.4.5 BASF Recent Development

11.5 Jubilant

11.5.1 Jubilant Company Detail

11.5.2 Jubilant Business Overview

11.5.3 Jubilant Fluorinated Pharmaceutical Intermediates Introduction

11.5.4 Jubilant Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.5.5 Jubilant Recent Development

11.6 Granules

11.6.1 Granules Company Detail

11.6.2 Granules Business Overview

11.6.3 Granules Fluorinated Pharmaceutical Intermediates Introduction

11.6.4 Granules Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.6.5 Granules Recent Development

11.7 Ganesh

11.7.1 Ganesh Company Detail

11.7.2 Ganesh Business Overview

11.7.3 Ganesh Fluorinated Pharmaceutical Intermediates Introduction

11.7.4 Ganesh Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.7.5 Ganesh Recent Development

11.8 Chemcon

11.8.1 Chemcon Company Detail

11.8.2 Chemcon Business Overview

11.8.3 Chemcon Fluorinated Pharmaceutical Intermediates Introduction

11.8.4 Chemcon Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.8.5 Chemcon Recent Development

11.9 Chemours

11.9.1 Chemours Company Detail

11.9.2 Chemours Business Overview

11.9.3 Chemours Fluorinated Pharmaceutical Intermediates Introduction

11.9.4 Chemours Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.9.5 Chemours Recent Development

11.10 Zhejiang Yongtai Technology

11.10.1 Zhejiang Yongtai Technology Company Detail

11.10.2 Zhejiang Yongtai Technology Business Overview

11.10.3 Zhejiang Yongtai Technology Fluorinated Pharmaceutical Intermediates Introduction

11.10.4 Zhejiang Yongtai Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.10.5 Zhejiang Yongtai Technology Recent Development

11.11 Shenzhen Capchem Technology

11.11.1 Shenzhen Capchem Technology Company Detail

11.11.2 Shenzhen Capchem Technology Business Overview

11.11.3 Shenzhen Capchem Technology Fluorinated Pharmaceutical Intermediates Introduction

11.11.4 Shenzhen Capchem Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.11.5 Shenzhen Capchem Technology Recent Development

11.12 Zhejiang Zhongxin Fluoride Materials

11.12.1 Zhejiang Zhongxin Fluoride Materials Company Detail

11.12.2 Zhejiang Zhongxin Fluoride Materials Business Overview

11.12.3 Zhejiang Zhongxin Fluoride Materials Fluorinated Pharmaceutical Intermediates Introduction

11.12.4 Zhejiang Zhongxin Fluoride Materials Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.12.5 Zhejiang Zhongxin Fluoride Materials Recent Development

11.13 Jiangsu Feiyu Technology

11.13.1 Jiangsu Feiyu Technology Company Detail

11.13.2 Jiangsu Feiyu Technology Business Overview

11.13.3 Jiangsu Feiyu Technology Fluorinated Pharmaceutical Intermediates Introduction

11.13.4 Jiangsu Feiyu Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.13.5 Jiangsu Feiyu Technology Recent Development

11.14 Shanghai Sinofluoro

11.14.1 Shanghai Sinofluoro Company Detail

11.14.2 Shanghai Sinofluoro Business Overview

11.14.3 Shanghai Sinofluoro Fluorinated Pharmaceutical Intermediates Introduction

11.14.4 Shanghai Sinofluoro Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.14.5 Shanghai Sinofluoro Recent Development

11.15 Shanghai Aqbiopharma

11.15.1 Shanghai Aqbiopharma Company Detail

11.15.2 Shanghai Aqbiopharma Business Overview

11.15.3 Shanghai Aqbiopharma Fluorinated Pharmaceutical Intermediates Introduction

11.15.4 Shanghai Aqbiopharma Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.15.5 Shanghai Aqbiopharma Recent Development

11.16 Hangzhou Fluoro Pharmaceutical

11.16.1 Hangzhou Fluoro Pharmaceutical Company Detail

11.16.2 Hangzhou Fluoro Pharmaceutical Business Overview

11.16.3 Hangzhou Fluoro Pharmaceutical Fluorinated Pharmaceutical Intermediates Introduction

11.16.4 Hangzhou Fluoro Pharmaceutical Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.16.5 Hangzhou Fluoro Pharmaceutical Recent Development

11.17 Zhejiang Dayang Biotech

11.17.1 Zhejiang Dayang Biotech Company Detail

11.17.2 Zhejiang Dayang Biotech Business Overview

11.17.3 Zhejiang Dayang Biotech Fluorinated Pharmaceutical Intermediates Introduction

11.17.4 Zhejiang Dayang Biotech Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.17.5 Zhejiang Dayang Biotech Recent Development

11.18 Shandong Feiyuan Group

11.18.1 Shandong Feiyuan Group Company Detail

11.18.2 Shandong Feiyuan Group Business Overview

11.18.3 Shandong Feiyuan Group Fluorinated Pharmaceutical Intermediates Introduction

11.18.4 Shandong Feiyuan Group Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

11.18.5 Shandong Feiyuan Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Zhejiang Yongtai Technology

Shenzhen Capchem Technology

Zhejiang Zhongxin Fluoride Materials

Zhejiang Dayang Biotech

Jiangsu Feiyu Technology

Shanghai Sinofluoro

Shanghai Aqbiopharma

Hangzhou Fluoro Pharmaceutical

Shandong Feiyuan Group

List of Tables

Table 1. Global Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Aromatic Fluoride

Table 3. Key Players of Aliphatic Fluoride

Table 4. Global Fluorinated Pharmaceutical Intermediates Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Fluorinated Pharmaceutical Intermediates Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Fluorinated Pharmaceutical Intermediates Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Fluorinated Pharmaceutical Intermediates Market Share by Region (2019-2024)

Table 8. Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Fluorinated Pharmaceutical Intermediates Market Share by Region (2025-2030)

Table 10. Fluorinated Pharmaceutical Intermediates Market Trends

Table 11. Fluorinated Pharmaceutical Intermediates Market Drivers

Table 12. Fluorinated Pharmaceutical Intermediates Market Challenges

Table 13. Fluorinated Pharmaceutical Intermediates Market Restraints

Table 14. Global Fluorinated Pharmaceutical Intermediates Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Fluorinated Pharmaceutical Intermediates Market Share by Players (2019-2024)

Table 16. Global Top Fluorinated Pharmaceutical Intermediates Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fluorinated Pharmaceutical Intermediates as of 2023)

Table 17. Ranking of Global Top Fluorinated Pharmaceutical Intermediates Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Fluorinated Pharmaceutical Intermediates Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Fluorinated Pharmaceutical Intermediates Product Solution and Service

Table 21. Date of Enter into Fluorinated Pharmaceutical Intermediates Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Fluorinated Pharmaceutical Intermediates Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Type (2019-2024)

Table 25. Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Type (2025-2030)

Table 27. Global Fluorinated Pharmaceutical Intermediates Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Application (2019-2024)

Table 29. Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Application (2025-2030)

Table 31. North America Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2025-2030) & (US$ Million)

Table 46. Lonza Company Detail

Table 47. Lonza Business Overview

Table 48. Lonza Fluorinated Pharmaceutical Intermediates Product

Table 49. Lonza Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 50. Lonza Recent Development

Table 51. Catalent Company Detail

Table 52. Catalent Business Overview

Table 53. Catalent Fluorinated Pharmaceutical Intermediates Product

Table 54. Catalent Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 55. Catalent Recent Development

Table 56. Patheon Company Detail

Table 57. Patheon Business Overview

Table 58. Patheon Fluorinated Pharmaceutical Intermediates Product

Table 59. Patheon Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 60. Patheon Recent Development

Table 61. BASF Company Detail

Table 62. BASF Business Overview

Table 63. BASF Fluorinated Pharmaceutical Intermediates Product

Table 64. BASF Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 65. BASF Recent Development

Table 66. Jubilant Company Detail

Table 67. Jubilant Business Overview

Table 68. Jubilant Fluorinated Pharmaceutical Intermediates Product

Table 69. Jubilant Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 70. Jubilant Recent Development

Table 71. Granules Company Detail

Table 72. Granules Business Overview

Table 73. Granules Fluorinated Pharmaceutical Intermediates Product

Table 74. Granules Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 75. Granules Recent Development

Table 76. Ganesh Company Detail

Table 77. Ganesh Business Overview

Table 78. Ganesh Fluorinated Pharmaceutical Intermediates Product

Table 79. Ganesh Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 80. Ganesh Recent Development

Table 81. Chemcon Company Detail

Table 82. Chemcon Business Overview

Table 83. Chemcon Fluorinated Pharmaceutical Intermediates Product

Table 84. Chemcon Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 85. Chemcon Recent Development

Table 86. Chemours Company Detail

Table 87. Chemours Business Overview

Table 88. Chemours Fluorinated Pharmaceutical Intermediates Product

Table 89. Chemours Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 90. Chemours Recent Development

Table 91. Zhejiang Yongtai Technology Company Detail

Table 92. Zhejiang Yongtai Technology Business Overview

Table 93. Zhejiang Yongtai Technology Fluorinated Pharmaceutical Intermediates Product

Table 94. Zhejiang Yongtai Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 95. Zhejiang Yongtai Technology Recent Development

Table 96. Shenzhen Capchem Technology Company Detail

Table 97. Shenzhen Capchem Technology Business Overview

Table 98. Shenzhen Capchem Technology Fluorinated Pharmaceutical Intermediates Product

Table 99. Shenzhen Capchem Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 100. Shenzhen Capchem Technology Recent Development

Table 101. Zhejiang Zhongxin Fluoride Materials Company Detail

Table 102. Zhejiang Zhongxin Fluoride Materials Business Overview

Table 103. Zhejiang Zhongxin Fluoride Materials Fluorinated Pharmaceutical Intermediates Product

Table 104. Zhejiang Zhongxin Fluoride Materials Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 105. Zhejiang Zhongxin Fluoride Materials Recent Development

Table 106. Jiangsu Feiyu Technology Company Detail

Table 107. Jiangsu Feiyu Technology Business Overview

Table 108. Jiangsu Feiyu Technology Fluorinated Pharmaceutical Intermediates Product

Table 109. Jiangsu Feiyu Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 110. Jiangsu Feiyu Technology Recent Development

Table 111. Shanghai Sinofluoro Company Detail

Table 112. Shanghai Sinofluoro Business Overview

Table 113. Shanghai Sinofluoro Fluorinated Pharmaceutical Intermediates Product

Table 114. Shanghai Sinofluoro Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 115. Shanghai Sinofluoro Recent Development

Table 116. Shanghai Aqbiopharma Company Detail

Table 117. Shanghai Aqbiopharma Business Overview

Table 118. Shanghai Aqbiopharma Fluorinated Pharmaceutical Intermediates Product

Table 119. Shanghai Aqbiopharma Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 120. Shanghai Aqbiopharma Recent Development

Table 121. Hangzhou Fluoro Pharmaceutical Company Detail

Table 122. Hangzhou Fluoro Pharmaceutical Business Overview

Table 123. Hangzhou Fluoro Pharmaceutical Fluorinated Pharmaceutical Intermediates Product

Table 124. Hangzhou Fluoro Pharmaceutical Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 125. Hangzhou Fluoro Pharmaceutical Recent Development

Table 126. Zhejiang Dayang Biotech Company Detail

Table 127. Zhejiang Dayang Biotech Business Overview

Table 128. Zhejiang Dayang Biotech Fluorinated Pharmaceutical Intermediates Product

Table 129. Zhejiang Dayang Biotech Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 130. Zhejiang Dayang Biotech Recent Development

Table 131. Shandong Feiyuan Group Company Detail

Table 132. Shandong Feiyuan Group Business Overview

Table 133. Shandong Feiyuan Group Fluorinated Pharmaceutical Intermediates Product

Table 134. Shandong Feiyuan Group Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)

Table 135. Shandong Feiyuan Group Recent Development

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Fluorinated Pharmaceutical Intermediates Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Fluorinated Pharmaceutical Intermediates Market Share by Type: 2023 VS 2030

Figure 3. Aromatic Fluoride Features

Figure 4. Aliphatic Fluoride Features

Figure 5. Global Fluorinated Pharmaceutical Intermediates Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Fluorinated Pharmaceutical Intermediates Market Share by Application: 2023 VS 2030

Figure 7. Antiviral Drug Case Studies

Figure 8. Anti-infectives Drug Case Studies

Figure 9. Antirheumatic Drug Case Studies

Figure 10. Antibacterial Drug Case Studies

Figure 11. Others Case Studies

Figure 12. Fluorinated Pharmaceutical Intermediates Report Years Considered

Figure 13. Global Fluorinated Pharmaceutical Intermediates Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Fluorinated Pharmaceutical Intermediates Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Fluorinated Pharmaceutical Intermediates Market Share by Region: 2023 VS 2030

Figure 16. Global Fluorinated Pharmaceutical Intermediates Market Share by Players in 2023

Figure 17. Global Top Fluorinated Pharmaceutical Intermediates Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fluorinated Pharmaceutical Intermediates as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Fluorinated Pharmaceutical Intermediates Revenue in 2023

Figure 19. North America Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Fluorinated Pharmaceutical Intermediates Market Share by Country (2019-2030)

Figure 21. United States Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Fluorinated Pharmaceutical Intermediates Market Share by Country (2019-2030)

Figure 25. Germany Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Share by Region (2019-2030)

Figure 33. China Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Fluorinated Pharmaceutical Intermediates Market Share by Country (2019-2030)

Figure 41. Mexico Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Share by Country (2019-2030)

Figure 45. Turkey Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Lonza Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 48. Catalent Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 49. Patheon Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 50. BASF Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 51. Jubilant Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 52. Granules Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 53. Ganesh Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 54. Chemcon Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 55. Chemours Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 56. Zhejiang Yongtai Technology Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 57. Shenzhen Capchem Technology Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 58. Zhejiang Zhongxin Fluoride Materials Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 59. Jiangsu Feiyu Technology Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 60. Shanghai Sinofluoro Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 61. Shanghai Aqbiopharma Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 62. Hangzhou Fluoro Pharmaceutical Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 63. Zhejiang Dayang Biotech Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 64. Shandong Feiyuan Group Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions